New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Bayer AG (BAYRY)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Article
Discussion
History
Bookmark
Print
Top Bears Reasons To Sell — Vote below!
0%
agree
FDA approval
Add a New Bears Reason
Company:
Bayer AG (BAYRY)
Current price:
Headline:
(100 character max)
Analysis:
Cancel
0%
agree
0
votes
FDA approval
Created when OTC:BAYRY was $46.45 |
Edit
|
History
New drug for hip replacement pts that would eliminate need for INR testing.
(100 character max)
Cancel
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour